These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 25581730)

  • 1. Expression profiles of MYC protein and MYC gene rearrangement in lymphomas.
    Chisholm KM; Bangs CD; Bacchi CE; Molina-Kirsch H; Cherry A; Natkunam Y
    Am J Surg Pathol; 2015 Mar; 39(3):294-303. PubMed ID: 25581730
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Aggressive B-cell non-Hodgkin lymphomas: a report of the lymphoma workshop of the 20th meeting of the European Association for Haematopathology.
    Rodriguez-Pinilla SM; Dojcinov S; Dotlic S; Gibson SE; Hartmann S; Klimkowska M; Sabattini E; Tousseyn TA; de Jong D; Hsi ED
    Virchows Arch; 2024 Jan; 484(1):15-29. PubMed ID: 37530792
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinical Interest of LMO2 Testing for the Diagnosis of Aggressive Large B-Cell Lymphomas.
    Vazquez I; Papaleo N; Garcia E; Salido M; Salar A; Hernandez S; Calvo X; Colomo L
    Cancers (Basel); 2020 Apr; 12(4):. PubMed ID: 32260556
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Predictive and prognostic molecular biomarkers in lymphomas.
    Iorgulescu JB; Medeiros LJ; Patel KP
    Pathology; 2024 Mar; 56(2):239-258. PubMed ID: 38216400
    [TBL] [Abstract][Full Text] [Related]  

  • 5. MYC-related microRNAs signatures in non-Hodgkin B-cell lymphomas and their relationships with core cellular pathways.
    Malpeli G; Barbi S; Tosadori G; Greco C; Zupo S; Pedron S; Brunelli M; Bertolaso A; Scupoli MT; Krampera M; Kamga PT; Croce CM; Calin GA; Scarpa A; Zamò A
    Oncotarget; 2018 Jul; 9(51):29753-29771. PubMed ID: 30038718
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Burkitt-like lymphoma with 11q aberration.
    Collins K; Mnayer L; Shen P
    Clin Case Rep; 2019 Sep; 7(9):1823-1824. PubMed ID: 31534767
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Composite Burkitt Lymphoma and Classical Hodgkin Lymphoma in an Human Immunodeficiency Virus (HIV)-Positive Patient.
    Smith D; Reid DM; Mascio AA; Noel BO; Giangreco M
    Cureus; 2024 Jun; 16(6):e62827. PubMed ID: 39040737
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Non-Secretory Multiple Myeloma Associated With High-Risk Phenotype and Complex Cytogenetics Including t(8;22).
    Jiwani RA; Liput JR; Abraham A; Alhamad K; Kapdi M; Mota R; Forte K; McGill JR; Acer JC; Nisarga P; Jaeger NR; Sadashiv S; Mewawalla P
    J Hematol; 2024 Jun; 13(3):94-98. PubMed ID: 38993738
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Establishment of a primary renal lymphoma model and its clinical relevance.
    Li X; Deng M; Zhang C; Luo L; Qian H
    Front Oncol; 2023; 13():1089187. PubMed ID: 37700827
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Should We Test for
    Saini T; Sharma P; Sachdeva MUS; Mallik N; Anshu A; Rathore S; Balakrishnan A; Bal A; Swain RN; Prakash G; Sreedharanunni S
    Indian J Hematol Blood Transfus; 2024 Jul; 40(3):540-542. PubMed ID: 39011251
    [No Abstract]   [Full Text] [Related]  

  • 11. MYC cytogenetic status correlates with expression and has prognostic significance in patients with MYC/BCL2 protein double-positive diffuse large B-cell lymphoma.
    Wang XJ; Medeiros LJ; Lin P; Yin CC; Hu S; Thompson MA; Li S
    Am J Surg Pathol; 2015 Sep; 39(9):1250-8. PubMed ID: 25828389
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Diagnosis of 'double hit' diffuse large B-cell lymphoma and B-cell lymphoma, unclassifiable, with features intermediate between DLBCL and Burkitt lymphoma: when and how, FISH versus IHC.
    Swerdlow SH
    Hematology Am Soc Hematol Educ Program; 2014 Dec; 2014(1):90-9. PubMed ID: 25696840
    [TBL] [Abstract][Full Text] [Related]  

  • 13. MYC alterations in diffuse large B-cell lymphomas.
    Karube K; Campo E
    Semin Hematol; 2015 Apr; 52(2):97-106. PubMed ID: 25805589
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Triple-hit B-cell Lymphoma With MYC, BCL2, and BCL6 Translocations/Rearrangements: Clinicopathologic Features of 11 Cases.
    Wang W; Hu S; Lu X; Young KH; Medeiros LJ
    Am J Surg Pathol; 2015 Aug; 39(8):1132-9. PubMed ID: 25828391
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Isolated MYC cytogenetic abnormalities in diffuse large B-cell lymphoma do not predict an adverse clinical outcome.
    Caponetti GC; Dave BJ; Perry AM; Smith LM; Jain S; Meyer PN; Bast M; Bierman PJ; Bociek RG; Vose JM; Armitage JO; Aoun P; Fu K; Greiner TC; Chan WC; Sanger WG; Weisenburger DD
    Leuk Lymphoma; 2015; 56(11):3082-9. PubMed ID: 25827211
    [TBL] [Abstract][Full Text] [Related]  

  • 16. MYC in diffuse large B-cell lymphoma: always the bad guy?
    Kersten MJ; Guikema JE
    Leuk Lymphoma; 2015; 56(11):3003-4. PubMed ID: 25944471
    [No Abstract]   [Full Text] [Related]  

  • 17. Changes in the influence of lymphoma- and HIV-specific factors on outcomes in AIDS-related non-Hodgkin lymphoma.
    Barta SK; Samuel MS; Xue X; Wang D; Lee JY; Mounier N; Ribera JM; Spina M; Tirelli U; Weiss R; Galicier L; Boue F; Little RF; Dunleavy K; Wilson WH; Wyen C; Remick SC; Kaplan LD; Ratner L; Noy A; Sparano JA
    Ann Oncol; 2015 May; 26(5):958-966. PubMed ID: 25632071
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cyclin D1-positive diffuse large B-cell lymphoma with IGH-CCND1 translocation and BCL6 rearrangement: a report of two cases.
    Al-Kawaaz M; Mathew S; Liu Y; Gomez ML; Chaviano F; Knowles DM; Orazi A; Tam W
    Am J Clin Pathol; 2015 Feb; 143(2):288-99. PubMed ID: 25596256
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The diagnostic gray zone between Burkitt lymphoma and diffuse large B-cell lymphoma is also a gray zone of the mutational spectrum.
    Momose S; Weißbach S; Pischimarov J; Nedeva T; Bach E; Rudelius M; Geissinger E; Staiger AM; Ott G; Rosenwald A
    Leukemia; 2015 Aug; 29(8):1789-91. PubMed ID: 25673238
    [No Abstract]   [Full Text] [Related]  

  • 20. Genetic lesions in diffuse large B-cell lymphomas.
    Testoni M; Zucca E; Young KH; Bertoni F
    Ann Oncol; 2015 Jun; 26(6):1069-1080. PubMed ID: 25605746
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.